These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1425730)

  • 1. Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.
    Berger EA; Pastan I
    PLoS Pathog; 2010 Jun; 6(6):e1000803. PubMed ID: 20548940
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAART.
    Berger EA; Moss B; Pastan I
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11511-3. PubMed ID: 9751696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression.
    Chao CC; Gekker G; Hu S; Sheng WS; Shark KB; Bu DF; Archer S; Bidlack JM; Peterson PK
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8051-6. PubMed ID: 8755601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
    Peterson PK; Gekker G; Hu S; Chao CC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2465-8. PubMed ID: 7530933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effects of CD4 derivatives.
    Capon DJ; Ward RH
    Curr Opin Immunol; 1989-1990 Feb; 2(3):433-8. PubMed ID: 2576772
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for the use of immunotoxins in the treatment of HIV-infected humans.
    Van Oijen MG; Preijers FW
    J Drug Target; 1998; 5(2):75-91. PubMed ID: 9588864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.
    Verhoef J; Gekker G; Erice A; Peterson PK; Balfour HH
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):715-21. PubMed ID: 1425730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cells.
    Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1091-6. PubMed ID: 8312052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
    Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
    Ashorn P; Moss B; Berger EA
    Ann N Y Acad Sci; 1990; 616():149-54. PubMed ID: 2078015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
    Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
    AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
    Ashorn P; Englund G; Martin MA; Moss B; Berger EA
    J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
    Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1080-6. PubMed ID: 3649230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
    Gill PS; Rarick M; Brynes RK; Causey D; Loureiro C; Levine AM
    Ann Intern Med; 1987 Oct; 107(4):502-5. PubMed ID: 3477107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Schooley RT
    N Engl J Med; 1987 Jul; 317(4):185-91. PubMed ID: 3299089
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.